These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 19042177

  • 21. 18F-FDG PET/Contrast-Enhanced CT for Initial Staging and Strategic Treatment of Non-Small Cell Lung Cancer: A Prospective Study.
    Promteangtrong C, Kunawudhi A, Phadungrerk R, Iamsa-art C, Chotipanich C.
    J Med Assoc Thai; 2015 Oct; 98(10):1010-8. PubMed ID: 26638593
    [Abstract] [Full Text] [Related]

  • 22. Value of FDG PET in the management of NSCLC.
    Ukena D, Hellwig D.
    Lung Cancer; 2004 Aug; 45 Suppl 2():S75-8. PubMed ID: 15552785
    [Abstract] [Full Text] [Related]

  • 23. Metabolic-morphologic discordant solitary skeletal muscle metastasis on [(18)F]fluorodeoxyglucose positron emission tomography/computed tomography scan in synchronous lung and esophageal cancer: a lesson.
    Lu SJ, Rodriguez-Justo M, Read S, Bomanji JB.
    J Clin Oncol; 2012 Mar 10; 30(8):e97-e101. PubMed ID: 22253463
    [No Abstract] [Full Text] [Related]

  • 24. False-negative rate after positron emission tomography/computer tomography scan for mediastinal staging in cI stage non-small-cell lung cancer.
    Gómez-Caro A, Boada M, Cabañas M, Sanchez M, Arguis P, Lomeña F, Ramirez J, Molins L.
    Eur J Cardiothorac Surg; 2012 Jul 10; 42(1):93-100; discussion 100. PubMed ID: 22290911
    [Abstract] [Full Text] [Related]

  • 25. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.
    Zhang H, Wroblewski K, Liao S, Kampalath R, Penney BC, Zhang Y, Pu Y.
    Acad Radiol; 2013 Jan 10; 20(1):32-40. PubMed ID: 22999369
    [Abstract] [Full Text] [Related]

  • 26. Mediastinal staging in Non-Small-Cell Lung Carcinoma: computed tomography versus F-18-fluorodeoxyglucose positron-emission tomography and computed tomography.
    Harders SW, Madsen HH, Hjorthaug K, Arveschoug AK, Rasmussen TR, Meldgaard P, Hoejbjerg JA, Pilegaard HK, Hager H, Rehling M, Rasmussen F.
    Cancer Imaging; 2014 Jun 03; 14(1):23. PubMed ID: 25608616
    [Abstract] [Full Text] [Related]

  • 27. Diagnostic value of fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography for the detection of metastases in non-small-cell lung cancer patients.
    Wu Y, Li P, Zhang H, Shi Y, Wu H, Zhang J, Qian Y, Li C, Yang J.
    Int J Cancer; 2013 Jan 15; 132(2):E37-47. PubMed ID: 22890912
    [Abstract] [Full Text] [Related]

  • 28. Diagnosis of recurrence and follow-up using FDG-PET/CT for postoperative non-small-cell lung cancer patients.
    Toba H, Kawakita N, Takashima M, Matsumoto D, Takizawa H, Otsuka H, Tangoku A.
    Gen Thorac Cardiovasc Surg; 2021 Feb 15; 69(2):311-317. PubMed ID: 32909168
    [Abstract] [Full Text] [Related]

  • 29. Significance of a new fluorodeoxyglucose-positive lesion on restaging positron emission tomography/computed tomography after induction therapy for non-small-cell lung cancer.
    Collaud S, Lardinois D, Tischler V, Steinert HC, Stahel R, Weder W.
    Eur J Cardiothorac Surg; 2012 Mar 15; 41(3):612-6. PubMed ID: 22219415
    [Abstract] [Full Text] [Related]

  • 30. Mediastinal lymph nodes staging by 18F-FDG PET/CT for early stage non-small cell lung cancer: a multicenter study.
    Li X, Zhang H, Xing L, Ma H, Xie P, Zhang L, Xu X, Yue J, Sun X, Hu X, Chen M, Xu W, Chen L, Yu J.
    Radiother Oncol; 2012 Feb 15; 102(2):246-50. PubMed ID: 22100657
    [Abstract] [Full Text] [Related]

  • 31. [Value of 18F-FDG PET in clinical staging of non-small-cell lung cancer].
    Liu SW, Yu JM, Xing LG.
    Zhonghua Zhong Liu Za Zhi; 2004 Oct 15; 26(10):626-9. PubMed ID: 15634527
    [Abstract] [Full Text] [Related]

  • 32. [Positron emission tomography in the diagnosis and follow up of non-small cell lung cancer].
    Vaylet F, Rivière F, Le Floch H, Bonnichon A, Mairovitz A, Staub E, Bonardel G, Margery J, Mantzarides M, Marotel C, Foehrenbach H.
    Rev Mal Respir; 2007 Oct 15; 24(8 Pt 2):6S35-9. PubMed ID: 18235392
    [Abstract] [Full Text] [Related]

  • 33. Thoracic staging with 18F-FDG PET/MR in non-small cell lung cancer - does it change therapeutic decisions in comparison to 18F-FDG PET/CT?
    Schaarschmidt BM, Grueneisen J, Metzenmacher M, Gomez B, Gauler T, Roesel C, Heusch P, Ruhlmann V, Umutlu L, Antoch G, Buchbender C.
    Eur Radiol; 2017 Feb 15; 27(2):681-688. PubMed ID: 27180186
    [Abstract] [Full Text] [Related]

  • 34. Selection of sublobar resection for c-stage IA non-small cell lung cancer based on a combination of structural imaging by CT and functional imaging by FDG PET.
    Yoshioka M, Ichiguchi O.
    Ann Thorac Cardiovasc Surg; 2009 Apr 15; 15(2):82-8. PubMed ID: 19471220
    [Abstract] [Full Text] [Related]

  • 35. Clinical significance of dual-time-point 18F-FDG PET imaging in resectable non-small cell lung cancer.
    Shimizu K, Okita R, Saisho S, Yukawa T, Maeda A, Nojima Y, Nakata M.
    Ann Nucl Med; 2015 Dec 15; 29(10):854-60. PubMed ID: 26254228
    [Abstract] [Full Text] [Related]

  • 36. Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography.
    Billé A, Pelosi E, Skanjeti A, Arena V, Errico L, Borasio P, Mancini M, Ardissone F.
    Eur J Cardiothorac Surg; 2009 Sep 15; 36(3):440-5. PubMed ID: 19464906
    [Abstract] [Full Text] [Related]

  • 37. Radioguided detection of lymph node metastasis in non-small cell lung cancer.
    Nwogu C, Fischer G, Tan D, Glinianski M, Lamonica D, Demmy T.
    Ann Thorac Surg; 2006 Nov 15; 82(5):1815-20; discussion 1820. PubMed ID: 17062254
    [Abstract] [Full Text] [Related]

  • 38. Exploring spatial overlap of high-uptake regions derived from dual tracer positron emission tomography-computer tomography imaging using 18F-fluorodeoxyglucose and 18F-fluorodeoxythymidine in nonsmall cell lung cancer patients: a prospective pilot study.
    Liu J, Li C, Hu M, Lu J, Shi X, Xing L, Sun X, Fu Z, Yu J, Meng X.
    Medicine (Baltimore); 2015 May 15; 94(17):e678. PubMed ID: 25929896
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.